Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
🚀 AI-picked stocks soar in May. PRFT is +55%—in just 16 days! Don’t miss June’s top picks. Unlock full list
Close

Bioelectronics Corp (BIEL)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
0.00010 -0.00010    -50.00%
22/05 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 12,076,449
  • Bid/Ask: 0.00000 / 0.00000
  • Day's Range: 0.00010 - 0.00020
Bioelectronics Corp 0.00010 -0.00010 -50.00%

BIEL Recent Sentiments

 
This page contains information on users’ sentiments for the Bioelectronics Corp stock, which are displayed both on charts of different periods of time and on a detailed table.
Start Date Username Call Open Rate End Date Chg. %
Mar 07, 2023 Tsongbird   0.00060 Mar 13, 2023 @ 0.00040 -33.33%
Dec 29, 2022 Tsongbird   0.00050 Jan 02, 2023 @ 0.00050 0.00%
Aug 31, 2022 Tsongbird   0.00085 Sep 05, 2022 @ 0.00080 -5.88%
Jul 20, 2022 Tsongbird   0.00095 Jul 25, 2022 @ 0.00100 +5.26%
May 30, 2022 Tsongbird   0.00080 Jun 06, 2022 @ 0.00100 +25.00%
May 30, 2022 Tsongbird   0.00080 Jun 06, 2022 @ 0.00100 +25.00%
Apr 05, 2022 Vicky Mateos   0.00110 Apr 11, 2022 @ 0.00100 -9.09%
Mar 09, 2022 Tsongbird   0.00100 Mar 14, 2022 @ 0.00100 0.00%
Aug 16, 2021 José Prados   0.00320 Sep 10, 2021 @ 0.00170 -46.88%
Aug 16, 2021 Zico Bertels   0.00315 Sep 10, 2021 @ 0.00170 -46.03%
Jul 30, 2021 Tsongbird   0.00329 Aug 02, 2021 @ 0.00340 +3.34%
Jul 16, 2021 José Prados   0.00270 Aug 06, 2021 @ 0.00325 +20.37%
Jun 01, 2021 José Prados   0.00290 Jun 25, 2021 @ 0.00270 -6.90%
Mar 15, 2021 Saad aldhafiri   0.00390 Apr 09, 2021 @ 0.00345 -11.54%
Mar 08, 2021 Andy Bock   0.00440 Apr 02, 2021 @ 0.00380 -13.64%
Feb 23, 2021 Mai Nguyen   0.00650 Mar 19, 2021 @ 0.00410 -36.92%
Feb 12, 2021 Alberto Maroñas Lopez   0.00680 Mar 05, 2021 @ 0.00426 -37.35%
Feb 11, 2021 Alberto Lara   0.00580 Mar 05, 2021 @ 0.00426 -26.55%
Feb 05, 2021 Than Nguyen   0.00360 Feb 26, 2021 @ 0.00477 +32.50%
Feb 03, 2021 John Scianni   0.00370 Feb 26, 2021 @ 0.00477 +28.92%
Feb 02, 2021 Obi Pittomvils   0.00380 Feb 26, 2021 @ 0.00477 +25.53%
Feb 01, 2021 Andy Bock   0.00400 Feb 16, 2021 @ 0.00695 +73.75%
Jan 27, 2021 Mark Corwin   0.00290 Feb 19, 2021 @ 0.00670 +131.03%
Jan 19, 2021 Andy Bock   0.00220 Feb 01, 2021 @ 0.00325 +47.73%
Nov 13, 2020 Mark Corwin   0.00130 Dec 04, 2020 @ 0.00120 -7.69%
Sep 05, 2019 Jacob Skulimowski   0.00080 Sep 27, 2019 @ 0.00080 0.00%
Oct 24, 2018 Angel Fernandez   0.00230 Nov 23, 2018 @ 0.00070 +69.57%
Feb 06, 2017 Christopher Zuidema   0.00160 Mar 08, 2017 @ 0.00120 -25.00%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

BIEL Comments

Write your thoughts about Bioelectronics Corp
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Tsong Bird
Tsongbird Mar 07, 2023 1:47PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
BioElectronics Corp made the top 50 innovative business list in Frederick Maryland.
Reply
1 0
Report
Tsong Bird
Tsongbird Dec 29, 2022 3:30PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The NO PAIN ACT is now LAW NO PAIN Act In March 2021, Senators Portman (R-OH), Shelley Moore Capito (R-WV), Jeanne Shaheen (D-NH), and Joe Manchin (D-WV) introduced the Non-Opioids Prevent Addiction in the Nation (NOPAIN) Act. The legislation aims to help address barriers to non-opioid pain management for those enrolled in Medicare, which will help stem the opioid epidemic across the nation. What does this mean for BioElectronics Corp? It means the future is now with Congressional approval. Medical devices like the Recovery RX could receive “Medical Device Reimbursement: Reimbursement for qualifying devices would be similar to the amount paid by a hospital or ASC for a medical device under transitional “pass-through” status. This reimbursement would be implemented through the creation of new payment categories (APCs) for qualifying treatments”
Reply
1 0
Report
Tsong Bird
Tsongbird Oct 24, 2022 8:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$BIEL It is business as usual for ActiPatch® in Asia
Reply
1 0
Report
Tsong Bird
Tsongbird Aug 31, 2022 10:33AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
BioElectronics Corp. (OTCPINK: BIEL) Heating Up as ActiPatch® and RecoveryRx® Gain Traction & Co Looks to Expand into New Markets
Reply
1 0
Report
Tsong Bird
Tsongbird Aug 02, 2022 4:58PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
New Update from Keith NalepkaPlease join me Thursday, August 25th@11amEST for our first Shareholder live call. I will be doing a 20 minute update on the company followed by QandA. Call in info will be provided one week in advance.
Reply
1 0
Report
Tsong Bird
Tsongbird Jun 03, 2022 12:22AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
The Recovery Rx is FDA approved. Read the clinical research https://www.recoveryrx.co/clinical-research/
Reply
1 0
Report
Tsong Bird
Tsongbird Jun 01, 2022 3:58PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$BIEL getting set up to sell SAI Actipatich products on Excel Health Canada
Reply
1 0
Report
Tsong Bird
Tsongbird Jun 01, 2022 11:06AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$BIEL Bioelectronics is a Game Changer
Reply
1 0
Report
Tsong Bird
Tsongbird Jun 01, 2022 10:56AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
There is a powerful future for Bioelectronics
Reply
1 0
Report
Tsong Bird
Tsongbird Jun 01, 2022 10:49AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
$BIEL is topping well over $100,000 a month in sales!BIEL has been busy since executing the OEM agreement with KT Health in December; the Company is now working with their three major channel partners, i.e., KT Health and Scott Specialties in the OTC space, and Medi-Launch in the prescription medical market, to solidify new orders after strong initial product launches that took place in Q1 2021. The Company is also pushing forward on the international sales front. In addition to re-acquiring their CE mark (which allows the Company to sell in most international countries) in late 2020, it also obtained MDSAP certification in Q1 2021, which now allows for product distribution in Canada, Australia, and New Zealand. More recently BIEL’s distribution partner in Mexico received authorization from Mexican FDA (Cofepris), which allows for the importation of the RecoveryRx® device into Mexico. Novro Med S.A. de C.V. has contracted for the exclusive distribution rights for RecoveryRx® in Mexico and it is expected that they will receive their initial stocking order during the 2nd quarter, 2022. The Company also entered into a distribution agreement with Madrid / Spain based PRIM Group for the distribution of its RecoveryRx device throughout Spain. As per latest filings BIEL is topping well over $100,000 a month in sales!
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email